ICU

SEC source: 0001213900-24-105214 · marketforms-67362.xml · derivative · entry 1

Vincent Bernadette N · CIK 0002047074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock, par value $0.0001 per share · 8,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ICU common stock.

F2 · derivative.exercise_date: The RSUs reported herein will vest in equal installments on the first, second and third anniversaries of June 4, 2024

F2 · derivative.expiration_date: The RSUs reported herein will vest in equal installments on the first, second and third anniversaries of June 4, 2024

SEC source: 0001213900-24-084108 · marketforms-67084.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,435

F1 · balance_after: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.

SEC source: 0001213900-24-077008 · marketforms-66986.xml · nonDerivative · entry 2

Green David A · CIK 0001372822 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,323

F3 · shares: Represents a grant of fully vested shares of the Issuer's common stock.

SEC source: 0001213900-25-017946 · marketforms-68494.xml · nonDerivative · entry 3

Neuman John · CIK 0002026279 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F3 · price: 3. The price reported in Column 4 is a weighted average price of $5.2396. These shares were purchased in multiple transactions at prices ranging from $5.19 to $5.24, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001213900-25-017946 · marketforms-68494.xml · nonDerivative · entry 2

Neuman John · CIK 0002026279 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F2 · price: 2. The price reported in Column 4 is a weighted average price of $4.3521. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.37, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001213900-25-017946 · marketforms-68494.xml · nonDerivative · entry 1

Neuman John · CIK 0002026279 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: 1. The price reported in Column 4 is a weighted average price of $3.6905. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.71, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001213900-24-077008 · marketforms-66986.xml · nonDerivative · entry 1

Green David A · CIK 0001372822 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,223

F1 · shares: Represents a grant of fully vested shares of the Issuer's common stock on a post reverse split basis. The original grant was for 55,556 shares.

F2 · shares: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of shares of common stock issued to the Reporting Person as of April 18, 2024 on a post-split basis.

SEC source: 0000929638-24-001498 · form4.xml · nonDerivative · entry 1

Lobo Andres · CIK 0001949731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,300

F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.

SEC source: 0000929638-24-001496 · form4.xml · nonDerivative · entry 1

Barnett Rick · CIK 0001949746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,664

F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.

SEC source: 0000929638-24-001502 · form4.xml · nonDerivative · entry 1

Green David A · CIK 0001372822 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 752,500

F1 · shares: Represents shares of the Issuer's common stock underlying restricted stock units ("RSUs") awarded to the Reporting Person. All shares reported herein will vest, subject to continued service, on the first anniversary of Mr. Green's appointment date. Twenty-five percent (25%) of the shares will vest upon completion of one (1) year of service measured from January 10, 2024, and the remaining seventy-five percent (75%) of the shares will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 10, 2025.

SEC source: 0000929638-24-001500 · form4.xml · nonDerivative · entry 1

Russell Richard D. · CIK 0001634290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,300

F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.

SEC source: 0000929638-24-001494 · form4.xml · nonDerivative · entry 1

Van Heel Kenneth · CIK 0001613111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,964

F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.

SEC source: 0000929638-24-001492 · form4.xml · nonDerivative · entry 1

Collins Allan · CIK 0001950453 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,343

F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.

SEC source: 0000929638-24-001490 · form4.xml · nonDerivative · entry 1

Rodgers Bruce M. · CIK 0001653727 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,515

F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance.

SEC source: 0001213900-24-077007 · marketforms-66983.xml · derivative · entry 1

Green David A · CIK 0001372822 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock, par value $0.0001 per share · 18,000 shares

Expires not disclosed

F1 · security: On April 16, 2024, a Form 4 (the "Original Report") was filed on behalf of the Reporting Person which inadvertently overstated the number of restricted stock unites ("RSUs") reported in Column 4 and Column 5 of Table I due to an administrative error. This Form 4 amendment is being filed to correct the aggregate number of RSUs issued to the Reporting Person as of the original transaction date from 30,100 RSUs (752,500 pre reverse split) to 18,000 RSUs (450,000 pre reverse split), and to report the grant of such RSUs on Table II, instead of Table I as set forth on the Original Report.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F3 · shares: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of RSUs granted to the Reporting Person as of April 12, 2024 on a post-split basis.

F4 · derivative.exercise_date: The RSUs will vest, subject to continued service, on the first anniversary of Mr. Green's appointment date. Twenty-five percent (25%) of the RSUs will vest upon completion of one (1) year of service measured from January 10, 2024, and the remaining seventy-five percent (75%) of the RSUs will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 10, 2025.

F4 · derivative.expiration_date: The RSUs will vest, subject to continued service, on the first anniversary of Mr. Green's appointment date. Twenty-five percent (25%) of the RSUs will vest upon completion of one (1) year of service measured from January 10, 2024, and the remaining seventy-five percent (75%) of the RSUs will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 10, 2025.

F3 · derivative.underlying_shares: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of RSUs granted to the Reporting Person as of April 12, 2024 on a post-split basis.

F3 · balance_after: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of RSUs granted to the Reporting Person as of April 12, 2024 on a post-split basis.

SEC source: 0000929638-23-003302 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 837,823

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-003300 · form4.xml · nonDerivative · entry 2

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,872

F3 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

F2 · balance_after: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4.

SEC source: 0000929638-23-003301 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,860

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-003222 · form4.xml · nonDerivative · entry 1

Van Heel Kenneth · CIK 0001613111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,400

SEC source: 0000929638-23-003300 · form4.xml · nonDerivative · entry 1

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,579

F1 · kind: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person.

F1 · shares: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person.

F2 · balance_after: Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4.

SEC source: 0000929638-23-002567 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 779,862

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002569 · form4.xml · nonDerivative · entry 1

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,506

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002568 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,490

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002513 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 738,753

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002511 · form4.xml · nonDerivative · entry 1

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,396

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002515 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,233

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-003234 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 736,466

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently overstated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1,428 shares. This error has been corrected on this Form 4.

SEC source: 0000929638-23-003235 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,181

F1 · shares: The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently overstated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 7,053 shares. This error has been corrected on this Form 4.

F2 · balance_after: Due to a rounding error, the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share. This error has been corrected on this Form 4.

F3 · balance_after: Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant.

SEC source: 0000929638-23-002301 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 703,575

F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002300 · form4.xml · nonDerivative · entry 1

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,022

F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-002302 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,055

F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.

SEC source: 0000929638-23-003233 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 702,176

F1 · shares: The securities reported in this transaction are issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently overstated the number of shares of Common Stock issued to the reporting person on August 15, 2023 by 859 shares. This error has been corrected on this Form 4.

SEC source: 0000929638-23-001847 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 682,399

F1 · shares: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. Such fully vested shares of common stock are issued as payment for the occurrence of an exit event bonus under that certain Transaction Bonus Agreement, dated as of December 23, 2021, as amended, between the Issuer and the Reporting Person.

F2 · balance_after: Includes 66,483 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001717 · form4.xml · nonDerivative · entry 2

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,991

F3 · shares: Represents shares withheld to satisfy tax withholding obligations.

F2 · balance_after: Includes 53,192 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001717 · form4.xml · nonDerivative · entry 1

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,061

F1 · shares: Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan.

F2 · balance_after: Includes 53,192 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001625 · form4.xml · nonDerivative · entry 4

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,125

F1 · balance_after: Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001625 · form4.xml · nonDerivative · entry 3

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,975

F1 · balance_after: Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001625 · form4.xml · nonDerivative · entry 2

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,675

F1 · balance_after: Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001625 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,675

F1 · balance_after: Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001610 · form4.xml · nonDerivative · entry 1

Russell Richard D. · CIK 0001634290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,978

F1 · balance_after: Includes 7,978 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001544 · form4.xml · nonDerivative · entry 1

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,582

F1 · balance_after: Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.

SEC source: 0000929638-23-001129 · form4.xml · derivative · entry 3

Chung Kevin · CIK 0001949950 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,483

Underlying: Common Stock · 66,483 shares

Expires 2033-04-06

F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

SEC source: 0000929638-23-001151 · form4.xml · derivative · entry 2

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,724

Underlying: Common Stock · 99,724 shares

Expires 2033-04-06

F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

SEC source: 0000929638-23-001151 · form4.xml · nonDerivative · entry 1

Schlorff Eric · CIK 0001949738 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,013

F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant.

SEC source: 0000929638-23-001147 · form4.xml · derivative · entry 2

Lobo Andres · CIK 0001949731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,967

Underlying: Common Stock · 11,967 shares

Expires 2033-04-06

F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

SEC source: 0000929638-23-001147 · form4.xml · nonDerivative · entry 1

Lobo Andres · CIK 0001949731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,978

F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant.

SEC source: 0000929638-23-001148 · form4.xml · derivative · entry 2

Barnett Rick · CIK 0001949746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,967

Underlying: Common Stock · 11,967 shares

Expires 2033-04-06

F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

SEC source: 0000929638-23-001148 · form4.xml · nonDerivative · entry 1

Barnett Rick · CIK 0001949746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,400

F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant.

SEC source: 0000929638-23-001152 · form4.xml · derivative · entry 2

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,621

Underlying: Common Stock · 16,621 shares

Expires 2033-04-06

F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.

SEC source: 0000929638-23-001152 · form4.xml · nonDerivative · entry 1

Baron Caryl · CIK 0001949735 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,192

F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant.